Autoimmune Conditions

Rare – Always Present and Never Forgotten

The experience of attending Rare Disease Day at the National Institutes of Health (NIH) exceeded the confines of the definition…

3 years ago

CRISPR Technology To Simplify And Enhance CAR T Cancer Treatment

This is a series on the advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new…

3 years ago

Got Covid? How Long Do You Have Protection After Catching the Virus?

HAVING COVID-19 PROVIDES DURABLE (BUT TEMPORARY) protection against getting severely sick in the future, no matter the variant.

3 years ago

Is the Covid Vaccine’s Spike Protein Killing Us?

What are the clinical reasons these vaccines cause death in some people?

3 years ago

Sudden Death, “Purebloods,” Myocarditis and more

Have we done a peer-review clinical review of COVID-related morbidity/mortality alongside people vaccinated who had serious side effects? Should we?

3 years ago

How COVID and the Power of Now Killed Scientific Peer Review

How long do or should clinical trials take – well, it depends – but often years. Science takes time. It…

3 years ago

Covid’s Elephant in the Room. We Must Address it

This article is based on probability, rather than certainty. The author is of the opinion that at some point the…

3 years ago

CAR T Therapy: From Cancer To Autoimmune Disease, The Lupus Example

Here we draw attention to promising findings for CAR T lupus treatment. The foundations of CAR T, as well as…

3 years ago

BQ.1 — The New COVID-19 Variant Doctors Want You to Know About

HAVE YOU HEARD ABOUT THE COVID-19 VARIANT BQ.1? This new virus on the block (or one of its variants) now comprises…

4 years ago

Celine Dion Has Stiff Person Syndrome. What You Need to Know

SUPERSTAR SINGER CELINE DION recently announced that he is postponing her European tour, given her development of a rare neurological…

4 years ago

This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.

Read More